Skip to main content
Premium Trial:

Request an Annual Quote

Downloads and Upgrades: RealTime StatMiner 5.0, Genome Workbench 2.7.15, and more

Premium

Integromics has released a new version of RealTime StatMiner, its software for analyzing data from qPCR experiments.

According to the company, version 5.0 has an improved data loader that better handles large data files from a variety of instrument platforms, and it has a new method for normalizing data across multiple plates. Also included is a new interactive Principal Component Analysis tool as well as new features for reporting analysis results, such as the automatic generation of gene lists showing altered expression between conditions and multiple comparison visualizations.


The National Center for Biotechnology Information has released Genome Workbench 2.7.15, an application for viewing and analyzing sequence data.

The updated version of the software includes new features such as a multiple alignment view, an active objects inspector, and binary packages for Linux OpenSUSE 13.1. Additional information on features, fixes, and improvements are available in the release notes.


The National Institutes of Health has made genetic data linked to medical information from the Genetic Epidemiology Research on Aging (GERA) project available in the database of genotypes and phenotypes.

The GERA project contains data from a cohort of more 78,000 individuals with an average age of 63. It is part of the Research Program on Genes, Environment, and Health, which includes more than 430,000 adult members of the Kaiser Permanente Northern California system.


Ensembl release 75 is available here.

The release includes a new VEP interface, a new track for human data, an updated Zebrafish gene set, new RNA-seq data for mouse, and more.


The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.